Tan, H. J. (2022). Oral Epigallocatechin Gallate Decreases Bioavailability Of Nadolol Via Modulation Of Ileal And Hepatic Oatp1a5, Mdr1a And Oct1 Mrna Levels In Spontaneously Hypertensive Rats.
Chicago Style (17th ed.) CitationTan, Hong Jie. Oral Epigallocatechin Gallate Decreases Bioavailability Of Nadolol Via Modulation Of Ileal And Hepatic Oatp1a5, Mdr1a And Oct1 Mrna Levels In Spontaneously Hypertensive Rats. 2022.
MLA (9th ed.) CitationTan, Hong Jie. Oral Epigallocatechin Gallate Decreases Bioavailability Of Nadolol Via Modulation Of Ileal And Hepatic Oatp1a5, Mdr1a And Oct1 Mrna Levels In Spontaneously Hypertensive Rats. 2022.
Warning: These citations may not always be 100% accurate.